Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7476 p500
3 November 2007

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• Certificates
• Publications
• The profession
• Supervision (2)
• Community pharmacy (2)
• Pack sizes
• Clinical trials
• Clostridium difficile
• The Journal
• Postgraduate education
• Retention fees


Letters to the Editor

Retention fees

Retention fees 2008

Reply from Martha Pawluczyk, adjudication manager, education and preregistration, at the Royal Pharmaceutical Society

Avoiding the retention fee

From Mr A. Matalia, MRPharmS

For locums and part-time pharmacists there may be a way to avoid paying a retention fee to the Royal Pharmaceutical Society and undertaking continuing professional development. They should attempt to register within the European Economic Area on a full-time basis on a similar footing as a pharmacist national. Once approved, they should resign their current British registration and then ask for free registration under the EU directive 2005/36/EC.

They may then work part-time or as a locum and, hey presto, no CPD to do in the UK and no exorbitant Society fee to pay.

This begs the question: if an EEA pharmacist does not have to pay a fee to work as a pharmacist in Britain, why should British pharmacists have to pay? The only solution is that all pharmacists should be able to register for free. Come on Mr Gush, surely this is fair.

A. Matalia
Coventry, West Midlands

 

MARTHA PAWLUCZYK, adjudication manager, education and preregistration, at the Royal Pharmaceutical Society, responds: What Mr Matalia refers to is EU Directive 2005/36/EC on the recognition of professional qualifications. The Directive covers all professions not just health care.

There is a provision in this Directive that enables a European Economic Area national who lives in another relevant European state and works as a pharmacist there to move to the UK to provide the same pharmacy services that he provides in his home country on a “temporary and occasional” basis.

The Directive does not define “temporary and occasional” because it is not possible to provide a definition that can apply to all professions in every country. It is for each profession in each country to provide advice on this. This means that there may be different interpretations in different countries for the same profession.

The following services for example could be regarded as temporary and occasional:

• A pharmacist who wishes to provide pharmacy services in another relevant European state following a disaster or state of emergency

• A pharmacist who wishes to provide pharmacy services during an international conference or sporting event in another relevant European state

The Directive requires the temporary and occasional nature of the provision of services to be assessed case by case in relation to its “duration, its frequency, its regularity and its continuity”. It is therefore highly unlikely that regular part-time locum work would be regarded as “temporary and occasional”.

In its response to the Department of Health’s consultation on legislation implementing this Directive, the Society urged the DoH to extend the CPD requirements to include temporary service providers. A press release regarding the Society’s response to this consultation can be found on the Society’s website. The Society awaits the outcome of this consultation and the new legislation amending the Pharmacists and Pharmacy Technicians Order, which we understand is imminent.

No registration fee is payable by persons wishing to provide temporary services because the service is of a temporary and occasional nature and the provider pays the fees to his home regulator to maintain his practising status in that country.

I can assure members that the Society is aware of the issue of temporary service provision and in its response to the DoH consultation has urged that in the interests of public and patient safety the regulatory system for temporary service providers is not weakened. The issue of temporary service provision will be monitored and matters raised with Government and the EU Commission as appropriate.

Send your letter to The Editor

Previous Topic (Postgraduate education)

Back to Top


©The Pharmaceutical Journal